|
| |
Scientific Programs of WCPGHAN 2012 |
| |
| Plenary Session (PS)
|
 |
| Plenary Session 1 : The Microbiome in Health and Disease” |
| Prof. Balfour Sartor (USA) |
| |
| Plenary Session 2 : Nutritional care and small bower rehabilitation in small bowel transplantation |
| Prof. Olivier Goulet (France) |
| |
| Plenary Session 3 : Breast feeding, intestinal colonization and programming of mucosal immunity |
| Prof. Allan Walker (USA) |
| |
| Plenary Session 4 : Impact of Climate Change on diarrheal disease and Nutrition |
| Prof. Ricardo Uauy (Chile) |
| |
| Plenary Session 5 : Liver Development and Regeneration- Implication from Bench to Clinical Therapy |
| Prof. Hiroshi Nishina (Japan) |
| |
| Gastroenterology Symposium (GS)
|
|
| Symposium G1. Inflammatory Bowel Disease |
| (1) Immunology, immunotherapy & other novel therapies in inflammatory bowel disease |
| Prof. Frank Ruemmele (France) |
| |
| (2) The Microbiome in inflammatory bowel disease |
| Prof. Ian Sanderson (UK) |
| |
| (3) Inflammatory bowel disease in the Developing World, Is it different from the West? |
| Prof. Vera Sdepanian (Brazil) |
| |
| Symposium G2. Celiac Disease |
| (1) Current and future guidelines for Celiac Disease |
| Prof. Ivor Hill (USA) |
| |
| (2) Novel therapy (vaccines and hookworm) for Celiac Disease |
| Prof. Frits Koning (Netherland) |
| |
| (3) Celiac disease in the developing world |
| Prof. Riccardo Troncone (Italy) |
| |
| Symposium G3. Gastrointestinal allergic disease |
| (1) New Developments in Eosinophilic Disease |
| Prof. Glenn Furuta (USA) |
| |
| (2) Breast milk immune tolerance for gastrointestinal allergic disease |
| Prof. Erika Isolaur ( Finland) |
| |
| (3) The role of the Gut Microbiota in both the etiology and treatment of childhood allergic disease |
| Prof. Ralf G. Heine (Australia) |
| |
| Liver Diseases Symposium (LS) |
|
| Symposium L1. Chronic Hepatitis |
| (1). Hepatitis B and D- Immunopathogenesis |
| Prof. Yen-Hsuan Ni (Taiwan) |
| |
| (2). Hepatitis C- New therapies and Vaccine development |
| Prof. Neelam Mohan ( India) |
| |
| (3). Autoimmune Liver Diseases-An Update |
| Prof. Giorgina Mieli-Vergani (U.K) |
| |
| Symposium L2. Metabolic liver diseases and NASH / NAFLD |
| (1)Advances in NASH/NAFLD –from Pathogenesis to management |
| Prof. Valerio Nobili (Italy) |
| |
| (2)Current Therapy in Citrin deficiency |
| Prof. Yusaku Tazawa (Japan) |
| |
| (3)New Concept in Mitochondria Hepatopathy |
| Prof. David Thorburn (Australia) |
| |
| Symposium L3. Cholestasis/ Cholangiopathy |
| (1) Development of the Liver and Biliary Tract in Normal and Diseases |
| Prof. Piccoli D (USA) |
| |
| (2) New Concept in Biliary Atresia |
| Prof. Bezerra J (USA) |
| |
| (3) Update on Bile Acid Transporter, Synthesis, and Metabolic Disorders |
| Prof. Richard Thompson (UK) |
| |
| Transplantation Symposium (TS) |
|
| Symposium T1. Transplantation of Liver and Bowel in Children |
| (1) Recent advances in the treatment of acute liver failure |
| Prof. Anil Dhawan (UK) |
| |
| (2) Cell based therapy of the liver: update and the future |
| Prof. Etienne Sokal (Belgium) |
| |
| (3) Long-term outcome after small bowel transplantation |
| Prof. Akin Tekin (USA) |
| |
| (4) Prevention and management of malignancy after organ transplantation |
| Prof. Po-Huang Lee (Taiwan) |
| |
| Nutrition Symposium (NS) |
|
| Symposium N1. Nutrition and Developmental Origins of Health and Disease |
| (1) Nutrition in Premature or LBW Infants and Catch-up Growth |
| Prof. Yuichiro Yamashiro (Japan) |
| |
| (2) Infants and childhood nutrition |
| Prof. Kim Michaelsen (Denmark) |
| |
| (3) Influence of early infant feeding practices and diet composition on later health |
| Prof . Susanna Huh (USA) |
| |
| Symposium N 2. Obesity and type II Diabetes |
| (1) Development of adipose tissue and obesity in relation to nutrition |
| Prof. Mitsuhiko Hara (Japan) |
| |
| (2) Microbiotome and Prevention of obesity in children |
| Prof. Luis Moreno (Spain) |
| |
| (3) Epidemiology and management of Childhood Obesity and Type II Diabetes |
| Prof. Jie Mi (China) |
| |
| Symposium N 3. Optimal nutrition for premature babies |
| (1) Concept of the new ESPGHAN recommendation for nutritional management of preterm infants |
| Prof. Johannes Van Goodoever (Netherland) |
| |
| (2) Calories, carbohydrate, protein, and LCPUFA |
| Prof. M. Makrides (Australia) |
| |
| (3) Complementary foods in former premature infants |
| Prof. Robert J. Shulman (USA) |
| |
| FISPGHAN Symposium (FS) |
|
| Symposium F1. Reaching the Goal of MDG4 by Fighting Against Diarrhea and Malnutirition |
| (1) Global Diarrhea Burden and Action Plan. |
| Prof. Olivier Fontaine (WHO) |
| |
| (2) The Global Burden of Undernutrition and Micronutrient deficiencies: what can be done? |
| Prof. Zulfiqar A Bhutta (Pakistan) |
| |
| (3) Severe acute malnutrition in childhood: intervention strategies. |
| Prof. Tahmeed Ahmed (Bangladesh) |
| |
| (4) HIV and infant feeding: global consensus |
| Prof. Usa Thisyakorn (Thailand) |
| |
| Endoscopy Symposium (ES) |
|
| Symposium E1. Genetics and endoscopic management for the intestinal polyposis in children |
| (1) Juvenile polyps and polyposis: genetics and endoscopic managements |
| Prof. John Barnard (USA) |
| |
| (2) Peutz Jeghers syndrome: genetic testing, endoscopic management, and long term follow-up |
| Prof. Victor Fox (USA) |
| |
| (3) Familial adenomatous polyposis syndrome: genetics, endoscopic management and adequate timing of total colectomy |
| Prof. Warren Hyer (UK) |
| |
| Symposium E 2.The 2012 updates and current status of pediatric GI endoscopic procedures – indications, complications and limitations |
| (1) Sedation in endoscopic procedures |
| Prof. Jenifer Lightdale (USA) |
| |
| (2) Capsule endoscopy in pediatrics |
| Prof. Stanley Cohen (USA) |
| |
| (3) Development of image diagnostic technology in pancreaticobiliary disorders |
| Prof. Takeshi Saito (Japan) |
| |
| Symposium E3. Therapeutic endoscopy in children - What’s new? |
| (1) Endoscopic evaluation and management of stricture in caustic esophagitis: adequate timing of stenting and balloon dilatation |
| Prof. Mike Thomson (UK) |
| |
| (2) Recent progress in the endoscopic management of non-variceal GI bleeding. |
| Prof. Marsha Kay (USA) |
| |
| (3) The role of endoscopic ultrasound in the diagnosis and management of pediatric GI diseases |
| Prof. Hsiu-Po Wang (Taiwan) |
| |
| (4) PEG - short and long term complications |
| Prof. Henrick Kohler (Germany) |
| |
| Portal Hypertension Symposium (PH) |
|
| Symposium P1- Portal Hypertension in Children |
| (1) Imaging of the portal hemodynamic in Liver cirrhosis |
| Prof. Yu-Fan Cheng (Taiwan) |
| |
| (2) Recent trends in endoscopic management |
| Dr. Kyung Mo Kim (Korea) |
| |
| (3) New trends in surgical treatment for portal hypertension |
| Prof. Hiroshi Yoshida(Japan) |
| |
| Post Graduate Course (PG) |
|
| I. Mechanisms and Implication for Therapy in Digestive Diseases |
| I-1. Inflammatory Bowel Disease -Pathophysiology and Advance in Diagnosis |
| Prof. Athos Bousvaros (USA)
|
| |
| I-2. Food Sensitive Enteropathy - Pathophysiology & Current Therapy |
| Prof. Toshiaki Shimizu (Japan) |
| |
| I-3. Post-Infectious Irritable Bowel Syndrome - Pathophysiology and Implication on Functional Gastrointestinal Disorders |
| Prof. Linda Chia-Hui Yu (Taiwan) |
| |
| 1-4. Impact of Epigenetics and Environments on gastrointestinal diseases |
| Prof. Richard Kellermayer (USA) |
| |
| I-5. Current and Emerging Therapies for Cyclic Vomiting |
| Prof. B. U. K Li (USA) |
| |
| II. Prevention and Early Detection of Digestive Diseases in Children |
| II-1. Prevention of Viral Hepatitis - from A to E |
| Prof. Kelly Deirdre (UK) |
| |
| II-2. Screening and Early Intervention of Cholestasis – The Effect on Outcome |
| Prof. Akira Matsui (Japan) |
| |
| II-3. H. pylori : Prevention and Therapy |
| Prof. Nicola Jones (Canada) |
| |
| II-4. Prevention and Management for Diarrheal Diseases – Vaccine and Beyond |
| Prof. Geoff Cleghorn (Australia) |
| |
| II-5. Early Detection and Emerging Management of Genetic and Metabolic Liver Disease |
| Prof. Ronald J Sokol (USA) |
| |
| II-6. Obesity, Diabetics and Intestinal Microbiome |
| Prof. Miriam Vos (USA) |
| |
| III. Challenges on the Management of Digestive Diseases in Children |
| III-1. GERD- Pathophysiology & Challenges on Current Strategy of Therapy |
| Prof. Harland Winter (U.S.A.) |
| |
| III-2. Probiotics in Health and Diseases – Dream or Reality |
| Prof. Erika Isolaur ( Finland) |
| |
| III-3. Management for Viral Hepatitis – When and How |
| Prof. Mei-Hwei Chang (Taiwan) |
| |
| III-4. Evaluation of Irritable Bowel Syndrome – When and How |
| Prof. Bhupinder Sandhu ( UK) |
| |
| III-5. Evaluation and Management of Malnutrition in the 21st Century |
| Prof. Sylvia Cruchet (Chile) |
| |
| IV. Management and Long Term Outcome of Digestive Diseases : From Childhood to Adult Life |
| IV-1. Long-term Outcome of early programming |
| Prof. Atul Singhal (India) |
| |
| IV-2. Long term Outcome of Biliary Atresia |
| Prof. Kathleen Schwarz (USA) |
| |
| IV-3. Long Term Outcome of Childhood Obesity |
| Prof. Walter Chen (Taiwan) |
| |
| |
